1. Home
  2. GRDN vs VERA Comparison

GRDN vs VERA Comparison

Compare GRDN & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Guardian Pharmacy Services Inc. Class A Common Stock

GRDN

Guardian Pharmacy Services Inc. Class A Common Stock

HOLD

Current Price

$29.35

Market Cap

1.7B

ML Signal

HOLD

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

HOLD

Current Price

$43.14

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRDN
VERA
Founded
2004
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Retail-Drug Stores and Proprietary Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.5B
IPO Year
2024
2021

Fundamental Metrics

Financial Performance
Metric
GRDN
VERA
Price
$29.35
$43.14
Analyst Decision
Strong Buy
Buy
Analyst Count
2
8
Target Price
$32.00
$61.71
AVG Volume (30 Days)
351.5K
1.8M
Earning Date
11-10-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.28
N/A
Revenue
$1,389,638,000.00
N/A
Revenue This Year
$19.50
N/A
Revenue Next Year
$0.48
N/A
P/E Ratio
$105.18
N/A
Revenue Growth
18.68
N/A
52 Week Low
$17.78
$18.53
52 Week High
$37.43
$50.37

Technical Indicators

Market Signals
Indicator
GRDN
VERA
Relative Strength Index (RSI) 56.79 78.66
Support Level $28.62 $32.66
Resistance Level $29.90 $34.43
Average True Range (ATR) 1.04 2.54
MACD -0.06 1.46
Stochastic Oscillator 62.26 96.85

Price Performance

Historical Comparison
GRDN
VERA

About GRDN Guardian Pharmacy Services Inc. Class A Common Stock

Guardian Pharmacy Services Inc is a differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing, and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs and BHFs. The operating segment derives its revenues through sales of pharmaceutical and medical products, and all revenues are derived solely in the United States.

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: